Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Aravive, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of ARAV: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3637+1
Shares4.56M5.24M+676.8K (+14.8%)
Value$9.99M$10.1M+$117.9K (+1.2%)

New holders (5)

Institutions that held Aravive, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ARAV in Q1 2022
InstitutionSharesValue% of portfolio
Armistice Capital, LLC934,975$1.80M0.05%
Bluefin Capital Management, LLC71,537$138.0K0.02%
Bradley & Co. Private Wealth Management, LLC18,339$35.0K0.03%
Citigroup Inc1,479$3.00K0.00%
Worth Asset Management, LLC120$00.00%

Sold out (4)

Institutions that held Aravive, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ARAV in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Walleye Capital LLC36,987$81.0K
Citadel Advisors LLC18,420$40.0K
Two Sigma Securities, LLC12,551$27.0K
FMR LLC650$1.00K